April 19, 2024 07:05 GMT
Sartorius (SRTGR; NR, BBB S) {SRT GR Equity}
HEALTHCARE
- Some notes of concern in earnings call on M&A & leverage targets - below - we'd price the curve to one notch lower/closer to pharma curves VTRS/Bayer till we see operating performance turnaround.
- The 26's still screen tad cheap at Z+72/3.95% as do the longer VTRS 27s at Z+92/4%.
48 words